Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial

2002317 citationsJournal Articlebronze Open Access

Authors

James W. Anderson · University of Kentucky

Frank L. Greenway · Pennington Biomedical Research Center

Ken Fujioka · Scripps Clinic

Kishore M. Gadde · Duke Medical Center

James M. McKenney · Virginia Commonwealth University

Patrick M. O’Neil · Medical University of South Carolina

Abstract

Bupropion SR 300 and 400 mg/d were well-tolerated by obese adults and were associated with a 24-week weight loss of 7.2% and 10.1% and sustained weight losses at 48 weeks.

Topics & Keywords

Pharmacology and Obesity Treatment Complementary and Alternative Medicine Studies Biochemical Analysis and Sensing Techniques

Publication Details

Published in: Obesity Research

Volume 10, Issue 7, pp. 633-641

DOI: 10.1038/oby.2002.86

Field-Weighted Citation Impact: 12.39

Command Palette

Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial

Authors

Abstract

Topics & Keywords

Publication Details